Rovazolac

$350$2,650

Products Details

Product Description

– Rovazolac is a liver x receptor (LXR) modulator extracted from patent WO2013130892A1.

Web ID

– HY-109073

Storage Temperature

– -20°C, 3 years; 4°C, 2 years (Powder)

Shipping

– Room Temperature

Applications

– COVID-19-immunoregulation

Molecular Formula

– C21H19F3N2O4S

References

– [1]Mohan R. Preparation of substituted pyrazoles as liver X receptor (LXR) modulators useful for the treatment of dermal diseases, disorders and conditions. WO2013130892A1

CAS Number

– 1454288-88-0

Molecular Weight

– 452.45

Compound Purity

– 99.68

SMILES

– O=C(OCC)CN1C(C2=CC=C(C3=CC(S(C)(=O)=O)=CC=C3)C=C2)=CC(C(F)(F)F)=N1

Clinical Information

– No Development Reported

Research Area

– Inflammation/Immunology

Solubility

– Ethanol : 10 mg/mL (ultrasonic)

Target

– LXR

Pathway

– Metabolic Enzyme/Protease;Vitamin D Related/Nuclear Receptor

Product type

– Reference compound

Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.

My Cart
Close Wishlist
Close Recently Viewed
Categories

Please fill out this form to request the file. We will send it to your Email address shortly. Thanks.

Please enable JavaScript in your browser to complete this form.

=

Please fill out this form to request the pricing.
We will send it to your email address shortly.
Thanks.

Please enable JavaScript in your browser to complete this form.

=